Monetary Solutions’s Takeda Pharmaceutical TAK Stock Holding History

Monetary Solutions’s Portfolio TAK Stock Details TAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$481	Buy	+30	New	+$496	﹤0.01%	342

Other funds holding TAK

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

MAP

Managed Asset Portfolios Rochester, Michigan $875M AUM 41.9% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

QCM

Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

CGH

Crossmark Global Holdings Houston, Texas $7.71B AUM 37.66% 1-Year Est. Return

Monetary Solutions's TAK Position: Q2 2026 in Review

Monetary Solutions opened a new position in Takeda Pharmaceutical (TAK) in Q2 2026: 30 shares worth $481. The stake represents ﹤0.01% of the portfolio and ranks #342 among its holdings.

297 funds tracked by Wall St. Rank hold TAK as of Q2 2026.

Monetary Solutions held 30 shares of Takeda Pharmaceutical worth $481 as of Q2 2026.
Takeda Pharmaceutical was a new Monetary Solutions position in Q2 2026.
Takeda Pharmaceutical made up ﹤0.01% of Monetary Solutions's portfolio in Q2 2026, its #342 holding.
297 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q2 2026.

Based on Monetary Solutions's 13F filing for Q2 2026, filed 23 Jul 2026.